Atlas Capital Advisors Inc. Buys Shares of 9,020 Cardinal Health, Inc. $CAH

Atlas Capital Advisors Inc. bought a new stake in Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 9,020 shares of the company’s stock, valued at approximately $1,854,000.

A number of other institutional investors also recently made changes to their positions in the business. Aptus Capital Advisors LLC raised its position in shares of Cardinal Health by 31.3% in the 4th quarter. Aptus Capital Advisors LLC now owns 3,370 shares of the company’s stock valued at $693,000 after purchasing an additional 803 shares in the last quarter. CreativeOne Wealth LLC raised its position in shares of Cardinal Health by 15.7% during the 4th quarter. CreativeOne Wealth LLC now owns 9,577 shares of the company’s stock valued at $1,968,000 after acquiring an additional 1,300 shares in the last quarter. Kestra Advisory Services LLC raised its position in shares of Cardinal Health by 13.8% during the 4th quarter. Kestra Advisory Services LLC now owns 20,241 shares of the company’s stock valued at $4,159,000 after acquiring an additional 2,458 shares in the last quarter. Transamerica Financial Advisors LLC raised its position in shares of Cardinal Health by 90.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 1,837 shares of the company’s stock valued at $377,000 after acquiring an additional 873 shares in the last quarter. Finally, Marshall Wace LLP raised its position in shares of Cardinal Health by 1,328.1% during the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after acquiring an additional 884,648 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $223.76 on Friday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The business’s fifty day moving average price is $203.21 and its two-hundred day moving average price is $208.85. The firm has a market capitalization of $52.41 billion, a PE ratio of 34.21, a P/E/G ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the company earned $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.19%.

Analyst Ratings Changes

Several research firms recently issued reports on CAH. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 7th. Leerink Partners reissued an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Morgan Stanley upped their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Finally, Barclays upped their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.